Aurora A Inhibitor I
Synonym(s):N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide;N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]-benzamide;TC‐S7010
- CAS NO.:1158838-45-9
- Empirical Formula: C31H31ClFN7O2
- Molecular Weight: 588.07
- MDL number: MFCD16495816
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-13 23:13:44
What is Aurora A Inhibitor I?
The Uses of Aurora A Inhibitor I
TC-S 7010 is a selective Aurora A inhibitor.
Definition
ChEBI: N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]anilino]-5-fluoro-4-pyrimidinyl]amino]benzamide is a member of benzamides.
Biological Activity
aurora a inhibitor i is a novel, potent, and selective inhibitor of aurora a .aurora kinases are reported to be required for mitosis and to complete cell division. because of this, aurora kinase inhibitors have been investigated extensively as potential anticancer therapeutic agents. the two major aurora kinases (aurora a and aurora b) are closely related in kinase domain sequence (71% identical).
in vitro
aurora a inhibitor i was tested against wild-type kinase and two mutants (aurora a (t217e) and aurora b (e161t)). the inhibitory potencies of aurora a inhibitor i was strongly affected by the single amino acid substitutions. for either aurora kinase, the presence of threonine allowed potent inhibition, while for glutamic acid variants, there was a approximately 100-fold shift in ic50, which supported the “gating” role for this residue. the aurora b binding pocket was enlarged by the e161t mutation, while the pocket in aurora a was closed by the t217e mutation. aurora a inhibitor i was exceptionally selective aurora a inhibitors, as shown by no inhibition on aurora b or cdks was observed in cellular assays [1].
Storage
Store at +4°C
References
[1] aliagas-martin i,burdick d,corson l,dotson j,drummond j,fields c,huang ow,hunsaker t,kleinheinz t,krueger e,liang j,moffat j,phillips g,pulk r,rawson te,ultsch m,walker l,wiesmann c,zhang b,zhu by,cochran ag. a class of 2,4-bisanilinopyrimidine aurora a inhibitors with unusually high selectivity against aurora b. j med chem.2009 may 28;52(10):3300-7.
Properties of Aurora A Inhibitor I
| Density | 1.362 |
| storage temp. | 2-8°C |
| solubility | DMSO: soluble10mg/mL, clear |
| form | powder |
| color | white to beige |
Safety information for Aurora A Inhibitor I
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral |
| Precautionary Statement Codes |
P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for Aurora A Inhibitor I
| InChIKey | AKSIZPIFQAYJGF-UHFFFAOYSA-N |
New Products
2-(2-aminoethyl) benzenesulfonamide Gemcitabine 3-benzoate impurity Dihydroxyphenylacetone Ornidazole EP impurity D Acetyl amino diol impurity Valsartan Benzyl Ester Impurity B N,N'-Dicyclohexylcarbodiimide 3-Bromo-2-Methyl-5-Nitropyridine 5-Bromo-3-Methyl-2-Pyridinecarboxylic acid 2-Amino-4-Methylpyridine 4-Aminopyridine 4-dimethylaminopyridineRelated products of tetrahydrofuran
You may like
-
Aurora A Inhibitor I 98.00% CAS 1158838-45-9View Details
1158838-45-9 -
Aurora-A Inhibitor I CAS 1158838-45-9View Details
1158838-45-9 -
4-(Methylnitrosoamino)-butanal NLT 95%View Details
339362-86-6 -
848696-99-1 NLT 95%View Details
848696-99-1 -
Ornidazole EP impurity A 1384752-15-1 NLT 95%View Details
1384752-15-1 -
615-81-6 Diisopropyl oxalate NLT 95%View Details
615-81-6 -
175481-38-6 Lacosamide EP Impurity F NLT 95%View Details
175481-38-6 -
Valsartan Related Compound A NLT 95%View Details
137862-87-4







